Changing Faces of Obstructive Sleep Apnea: Treatment Effects by Cluster Designation in the Icelandic Sleep Apnea Cohort

Grace W. Pien, Lichuan Ye, Brendan T. Keenan, Greg Maislin, Erla Björnsdóttir, Erna Sif Arnardottir, Bryndis Benediktsdottir, Thorarinn Gislason, Allan I. Pack

Research output: Contribution to journalArticle

Abstract

Study Objectives Distinct clinical phenotypes of obstructive sleep apnea (OSA) have been identified: Disturbed Sleep, Minimally Symptomatic, and Sleepy. Determining whether these phenotypes respond differently to standard treatment helps us to create a foundation for personalized therapies. We compared responses to positive airway pressure (PAP) therapy in these clinical OSA phenotypes. Methods The study sample included 706 patients from the Icelandic Sleep Apnea Cohort with moderate-to-severe OSA who were prescribed PAP. Linear and logistic mixed models were used to compare 2-year changes in demographics, comorbid diseases, and sleep-related health issues within and across OSA clinical phenotypes. Relationships between changes in symptoms and PAP adherence were also examined. Results Overall, effect sizes were moderate to large when comparing sleepiness, insomnia-related, and apneic symptom changes in the Sleepy group with changes in other two groups, especially those in the Minimally Symptomatic group. Within the Disturbed Sleep group, PAP users and nonusers demonstrated similar changes in insomnia-related symptoms. The Minimally Symptomatic group remained relatively asymptomatic, but reported significant decreases in daytime sleepiness and physical fatigue; PAP users generally had larger improvements. The Sleepy group had reductions in nearly all measured symptoms, including large reductions in drowsy driving; almost all of these improvements were greater among PAP users than nonusers. Conclusions OSA treatment response patterns differed by initial clinical phenotype and PAP adherence. Individuals with insomnia-related symptoms may require additional targeted therapy for these complaints. These findings underscore the need for a personalized approach to management that recognizes patients with a range of OSA presentations.

Original languageEnglish (US)
JournalSleep
Volume41
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Sleep Apnea Syndromes
Obstructive Sleep Apnea
Pressure
Phenotype
Sleep Initiation and Maintenance Disorders
Sleep
Therapeutics
Fatigue
Logistic Models
Demography
Health

Keywords

  • cluster analysis
  • obstructive sleep apnea
  • phenotypes of OSA
  • positive airway pressure
  • treatment outcome

ASJC Scopus subject areas

  • Clinical Neurology
  • Physiology (medical)

Cite this

Changing Faces of Obstructive Sleep Apnea : Treatment Effects by Cluster Designation in the Icelandic Sleep Apnea Cohort. / Pien, Grace W.; Ye, Lichuan; Keenan, Brendan T.; Maislin, Greg; Björnsdóttir, Erla; Arnardottir, Erna Sif; Benediktsdottir, Bryndis; Gislason, Thorarinn; Pack, Allan I.

In: Sleep, Vol. 41, No. 3, 01.03.2018.

Research output: Contribution to journalArticle

Pien, GW, Ye, L, Keenan, BT, Maislin, G, Björnsdóttir, E, Arnardottir, ES, Benediktsdottir, B, Gislason, T & Pack, AI 2018, 'Changing Faces of Obstructive Sleep Apnea: Treatment Effects by Cluster Designation in the Icelandic Sleep Apnea Cohort', Sleep, vol. 41, no. 3. https://doi.org/10.1093/sleep/zsx201
Pien, Grace W. ; Ye, Lichuan ; Keenan, Brendan T. ; Maislin, Greg ; Björnsdóttir, Erla ; Arnardottir, Erna Sif ; Benediktsdottir, Bryndis ; Gislason, Thorarinn ; Pack, Allan I. / Changing Faces of Obstructive Sleep Apnea : Treatment Effects by Cluster Designation in the Icelandic Sleep Apnea Cohort. In: Sleep. 2018 ; Vol. 41, No. 3.
@article{7a6f8c6e87974fbab8cc2e5cc260cca3,
title = "Changing Faces of Obstructive Sleep Apnea: Treatment Effects by Cluster Designation in the Icelandic Sleep Apnea Cohort",
abstract = "Study Objectives Distinct clinical phenotypes of obstructive sleep apnea (OSA) have been identified: Disturbed Sleep, Minimally Symptomatic, and Sleepy. Determining whether these phenotypes respond differently to standard treatment helps us to create a foundation for personalized therapies. We compared responses to positive airway pressure (PAP) therapy in these clinical OSA phenotypes. Methods The study sample included 706 patients from the Icelandic Sleep Apnea Cohort with moderate-to-severe OSA who were prescribed PAP. Linear and logistic mixed models were used to compare 2-year changes in demographics, comorbid diseases, and sleep-related health issues within and across OSA clinical phenotypes. Relationships between changes in symptoms and PAP adherence were also examined. Results Overall, effect sizes were moderate to large when comparing sleepiness, insomnia-related, and apneic symptom changes in the Sleepy group with changes in other two groups, especially those in the Minimally Symptomatic group. Within the Disturbed Sleep group, PAP users and nonusers demonstrated similar changes in insomnia-related symptoms. The Minimally Symptomatic group remained relatively asymptomatic, but reported significant decreases in daytime sleepiness and physical fatigue; PAP users generally had larger improvements. The Sleepy group had reductions in nearly all measured symptoms, including large reductions in drowsy driving; almost all of these improvements were greater among PAP users than nonusers. Conclusions OSA treatment response patterns differed by initial clinical phenotype and PAP adherence. Individuals with insomnia-related symptoms may require additional targeted therapy for these complaints. These findings underscore the need for a personalized approach to management that recognizes patients with a range of OSA presentations.",
keywords = "cluster analysis, obstructive sleep apnea, phenotypes of OSA, positive airway pressure, treatment outcome",
author = "Pien, {Grace W.} and Lichuan Ye and Keenan, {Brendan T.} and Greg Maislin and Erla Bj{\"o}rnsd{\'o}ttir and Arnardottir, {Erna Sif} and Bryndis Benediktsdottir and Thorarinn Gislason and Pack, {Allan I.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1093/sleep/zsx201",
language = "English (US)",
volume = "41",
journal = "Sleep",
issn = "0161-8105",
publisher = "American Academy of Sleep Medicine",
number = "3",

}

TY - JOUR

T1 - Changing Faces of Obstructive Sleep Apnea

T2 - Treatment Effects by Cluster Designation in the Icelandic Sleep Apnea Cohort

AU - Pien, Grace W.

AU - Ye, Lichuan

AU - Keenan, Brendan T.

AU - Maislin, Greg

AU - Björnsdóttir, Erla

AU - Arnardottir, Erna Sif

AU - Benediktsdottir, Bryndis

AU - Gislason, Thorarinn

AU - Pack, Allan I.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Study Objectives Distinct clinical phenotypes of obstructive sleep apnea (OSA) have been identified: Disturbed Sleep, Minimally Symptomatic, and Sleepy. Determining whether these phenotypes respond differently to standard treatment helps us to create a foundation for personalized therapies. We compared responses to positive airway pressure (PAP) therapy in these clinical OSA phenotypes. Methods The study sample included 706 patients from the Icelandic Sleep Apnea Cohort with moderate-to-severe OSA who were prescribed PAP. Linear and logistic mixed models were used to compare 2-year changes in demographics, comorbid diseases, and sleep-related health issues within and across OSA clinical phenotypes. Relationships between changes in symptoms and PAP adherence were also examined. Results Overall, effect sizes were moderate to large when comparing sleepiness, insomnia-related, and apneic symptom changes in the Sleepy group with changes in other two groups, especially those in the Minimally Symptomatic group. Within the Disturbed Sleep group, PAP users and nonusers demonstrated similar changes in insomnia-related symptoms. The Minimally Symptomatic group remained relatively asymptomatic, but reported significant decreases in daytime sleepiness and physical fatigue; PAP users generally had larger improvements. The Sleepy group had reductions in nearly all measured symptoms, including large reductions in drowsy driving; almost all of these improvements were greater among PAP users than nonusers. Conclusions OSA treatment response patterns differed by initial clinical phenotype and PAP adherence. Individuals with insomnia-related symptoms may require additional targeted therapy for these complaints. These findings underscore the need for a personalized approach to management that recognizes patients with a range of OSA presentations.

AB - Study Objectives Distinct clinical phenotypes of obstructive sleep apnea (OSA) have been identified: Disturbed Sleep, Minimally Symptomatic, and Sleepy. Determining whether these phenotypes respond differently to standard treatment helps us to create a foundation for personalized therapies. We compared responses to positive airway pressure (PAP) therapy in these clinical OSA phenotypes. Methods The study sample included 706 patients from the Icelandic Sleep Apnea Cohort with moderate-to-severe OSA who were prescribed PAP. Linear and logistic mixed models were used to compare 2-year changes in demographics, comorbid diseases, and sleep-related health issues within and across OSA clinical phenotypes. Relationships between changes in symptoms and PAP adherence were also examined. Results Overall, effect sizes were moderate to large when comparing sleepiness, insomnia-related, and apneic symptom changes in the Sleepy group with changes in other two groups, especially those in the Minimally Symptomatic group. Within the Disturbed Sleep group, PAP users and nonusers demonstrated similar changes in insomnia-related symptoms. The Minimally Symptomatic group remained relatively asymptomatic, but reported significant decreases in daytime sleepiness and physical fatigue; PAP users generally had larger improvements. The Sleepy group had reductions in nearly all measured symptoms, including large reductions in drowsy driving; almost all of these improvements were greater among PAP users than nonusers. Conclusions OSA treatment response patterns differed by initial clinical phenotype and PAP adherence. Individuals with insomnia-related symptoms may require additional targeted therapy for these complaints. These findings underscore the need for a personalized approach to management that recognizes patients with a range of OSA presentations.

KW - cluster analysis

KW - obstructive sleep apnea

KW - phenotypes of OSA

KW - positive airway pressure

KW - treatment outcome

UR - http://www.scopus.com/inward/record.url?scp=85043572506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043572506&partnerID=8YFLogxK

U2 - 10.1093/sleep/zsx201

DO - 10.1093/sleep/zsx201

M3 - Article

C2 - 29301021

AN - SCOPUS:85043572506

VL - 41

JO - Sleep

JF - Sleep

SN - 0161-8105

IS - 3

ER -